Peptonic Medical
0.00 SEK
+20.00 %
Less than 1K followers
PMED
Spotlight Stock Market
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Valuation
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Peptonic Medical
EV/S
Median 2019-2024
P/B
Median 2019-2025
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Share price (SEK) | 0.76 | 0.73 | 0.27 | 0.06 | 0.04 | 0.00 | 0.00 |
| Shares | 317.9 | 383.6 | 451.2 | 571.5 | 1,692.6 | 6,399.2 | 10,374.9 |
| Market cap | 240.3 | 281.5 | 119.8 | 34.0 | 68.2 | 21.9 | 18.7 |
| Enterprise value | 204.3 | 249.7 | 125.0 | 34.6 | 66.8 | 30.7 | - |
| EV/S | 46.4 | 11.7 | 3.9 | 0.8 | 1.8 | 1.1 | - |
| EV/EBITDA | neg. | neg. | neg. | neg. | neg. | neg. | - |
| EV/EBIT | neg. | neg. | neg. | neg. | neg. | neg. | - |
| P/E | neg. | neg. | neg. | neg. | neg. | neg. | - |
| P/B | 2.80 | 2.39 | 2.30 | 0.72 | 0.90 | 0.45 | 0.49 |
| P/S | 54.5 | 13.2 | 3.8 | 0.8 | 1.8 | 0.8 | 1.3 |
| Dividend yield | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % |
| Equity ratio | 93.2 % | 87.6 % | 62.3 % | 54.9 % | 70.6 % | 68.8 % | 58.0 % |
| Gearing ratio | 0.0 % | 6.4 % | 29.5 % | 8.9 % | 18.3 % | 25.9 % | 24.6 % |